Is hyponatremia a novel marker of inflammation in patients with COVID-19?
- 27 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 38 (8) , 1921-1924
Abstract
Juan C Ayus, Kamyar Kalantar-Zadeh, Ekamol Tantisattamo, Connie M Rhee, Armando Luis Negri; Is hyponatremia a novel marker of inflammation in patients with COVIKeywords
This publication has 25 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- SIADH in Systemic JIA Resolving After Treatment With an IL-6 InhibitorPediatrics, 2018
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Hyponatremia and Inflammation: The Emerging Role of Interleukin-6 in OsmoregulationNephron Physiology, 2010
- Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6Physiological Reviews, 2008
- Exercise-Associated Hyponatremia: Role of CytokinesThe American Journal of Medicine, 2006
- Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgeryJournal of Clinical Anesthesia, 1997
- Cytokine inhibitors in autoimmune diseaseSeminars in Arthritis and Rheumatism, 1996
- Interleukin‐1β Stimulates both Central and Peripheral Release of Vasopressin and Oxytocin in the RatEuropean Journal of Neuroscience, 1995
- Postoperative HyponatremiaArchives of internal medicine (1960), 1986